Star City Recovery: Luxury Rehab and Addiction Treatment Facility for Alcohol and Drugs in Tarzana, California

1 year ago

Detox Treatment With Different Options for Addiction No Matter What Substance You Struggle WithLOS ANGELES, CA / ACCESSWIRE / October…

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market

1 year ago

Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to capitalize…

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

1 year ago

PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today…

Moderna to Present at Upcoming Conferences in November 2024

1 year ago

CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming…

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

1 year ago

The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE…

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

1 year ago

BASKING RIDGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative…

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

1 year ago

Digital Marketing Initiatives to Highlight Innovative Non-Invasive Drug Screening Technology and Market Expansion PlansNEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE)…

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

1 year ago

Conference call and webcast to begin at 8:30 AM ETAUSTIN, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc.…

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024

1 year ago

LAWRENCEVILLE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated…

Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis

1 year ago

Targeted, better-tolerated oral PDE4 inhibitors are an unmet need in inflammatory bowel disease (IBD) PALI-2108 demonstrates in ex vivo studies;…